Testing of the Addition of a New Anti-cancer Drug, Molibresib, to Chemotherapy Treatment (Etoposide and Cisplatin) for Patients With NUT Carcinoma
Clinical trial NCT04116359 · WITHDRAWN
Trial details
- NCT number
- NCT04116359
- Sponsor
- National Cancer Institute (NCI)
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-18
- Primary completion
- 2020-09-18
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.